Physiomics plc (PYC) ORD GBP0.004
Share news, reports & tips
31 July 2020 12:08
(Sharecast News) - Oncology consultancy Physiomics announced on Friday that it has been awarded a contract by a new client, Japan-based global pharmaceutical company Astellas Pharma.
27 May 2020 10:30
(Sharecast News) - Oncology consultancy Physiomics has raised roughly £829,000 through a share issue to finance further development.
10 March 2020 11:39
(Sharecast News) - Oncology consulting company Physiomics has received a 'Connect' award from the National Institute for Health Research's (NIHR) 'Invention for Innovation' (i4i)...
3 March 2020 10:19
(Sharecast News) - Oncology consultancy Physiomics said on Tuesday that interim losses had widened despite posting an improvement in revenues.
23 December 2019 08:33
(Sharecast News) - Oncology consultancy business Physiomics has been awarded a further project agreement with British biotech outfit CellCentric.
20 December 2019 11:27
(Sharecast News) - Shares of Physiomics leapt on Friday after it signed up to a £250,000 tranche of projects with pharmaceutical giant Merck and said trading was in line with expectations.
30 July 2019 15:09
(Sharecast News) - Cancer treatment prediction technology provider Physiomics confirmed on Tuesday that, based on its unaudited management accounts for the year ended 30 June, it was trading in line with...
28 June 2019 10:56
(Sharecast News) - Cancer treatment technology provider Physiomics has been awarded a contract by Nasdaq-listed Bicycle Therapeutics, it announced on Friday.
21 February 2019 11:51
(Sharecast News) - Physiomics on Thursday reported a narrowed interim loss after the cancer monitoring technology provider more than doubled its revenue over the period.
3 January 2019 14:32
(Sharecast News) - Physiomics has entered into a strategic collaboration with the 'Medicines Discovery Catapult', it announced on Thursday.
17 December 2018 14:59
(Sharecast News) - Physiomics announced on Monday that, following a successful collaboration and pursuant to the master services agreement signed with US pharmaceuticals giant Merck in November last year, it...
9 August 2018 14:58
(Sharecast News) - Cancer treatment prediction technology developer Physiomics has been awarded a contract by a new European biotech client, it announced on Thursday.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2020. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.